Evidence map›Paper›PMID 32727390›Full record

ArticleBMC gastroenterology2020

Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report.

Meredith Buck, Igor Dumic, Wendy McDermott, Charles Nordstrom, Samarth Dawan, Andrew Virata, Scott Martin, Ann Hudson, Tamara Milovanovic, Terri Nordin

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Leukocytoclastic Vasculitis in a Patient With Crohn Disease: A Case Report.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Meredith BuckMayo Clinic Family Medicine Residency - Eau Claire Program, Eau Claire, WI, USA.
Igor DumicMayo Clinic Alix College of Medicine and Science, Rochester, MN, USA. Dumic.Igor@mayo.edu.ORCID http://orcid.org/0000-0002-5312-8812
Wendy McDermottMayo Clinic Alix College of Medicine and Science, Rochester, MN, USA.
Charles NordstromMayo Clinic Alix College of Medicine and Science, Rochester, MN, USA.
Samarth DawanIcahn School of Medicine at Mount Sinai, New York City, NY, USA.
Andrew VirataMayo Clinic Alix College of Medicine and Science, Rochester, MN, USA.
Scott MartinMayo Clinic Alix College of Medicine and Science, Rochester, MN, USA.
Ann HudsonMayo Clinic Alix College of Medicine and Science, Rochester, MN, USA.
Tamara MilovanovicDepartment of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia.
Terri NordinMayo Clinic Family Medicine Residency - Eau Claire Program, Eau Claire, WI, USA.
Mayo Clinic · USUniversity of Wisconsin–Eau Claire · USCentar za Promociju Nauke · RSIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeukocytoclastic vasculitis (LCV) is an immune-complex mediated vasculitis characterized by neutrophilic inflammation and nuclear debris in post capillary venules. LCV is a rare dermatologic manifestation of Crohn's disease (CD) and may occur with the onset of the disease or any time after the diagnosis including the period of exacerbation. CASE PRESENTATION: We present a 70 year old woman with history of psoriasis and treatment refractory CD requiring monoclonal antibody therapy with ustekinumab. One month prior to the current admission, she developed abdominal pain, worsening diarrhea and was diagnosed with CD exacerbation for which she was given ustekinumab. While her abdominal symptoms mildly improved with ustekinumab, she developed new bilateral lower extremity rash initially treated with levofloxacin for presumed cellulitis. The rash consisted of mild erythematous, non-scaling patches with scattered non-palpable petechiae on the lower extremities with subsequent involvement of abdomen, lower back and buttocks. Abdominal exam showed diffuse tenderness without mass, guarding or rebound while reminder of physical exam was unremarkable. Following the failure of antimicrobial therapy, she was diagnosed with LCV by skin biopsy. Complete work up was negative for infectious, malignant and inflammatory etiologies of LCV. Patient improved with increased dose of budesonide and subsequently continued to tolerate ustekinumab without recurrence of LCV. DISCUSSION AND

conclusionLCV is a rare form of vasculitis and one of the rarest dermatologic manifestations of CD, appearing at any stage of the disease. LCV has been associated with autoimmune diseases, infections, specific drugs (levofloxacin, ustekinumab), and malignancy. Clinical presentation of LCV is variable and frequently mistaken for cellulitis. LCV should be considered in differential diagnosis of bilateral lower extremity rash in patients with CD after infectious, malignant and auto-immune/inflammatory etiologies are excluded. Unlike erythema nodosum (EN) and pyoderma gangrenosum (PG), LCV requires biopsy for diagnosis. Most patients respond well to steroids without scarring.

Indexed as

Crohn DiseaseVasculitis, Leukocytoclastic, CutaneousAgedCellulitisFemaleHumansUstekinumabUstekinumabCase reportCellulitisCrohn’s diseaseDermatologic manifestationInflammatory bowel diseaseLeukocytoclastic vasculitisLevofloxacinUstekinumab

Identifiers

PMID32727390
PMCPMC7389435
OpenAlexW3046073318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.